Piper Sandler Upgrades Exact Sciences to Overweight, Announces $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg has upgraded Exact Sciences (NASDAQ:EXAS) from Neutral to Overweight and set a price target of $90.
October 10, 2023 | 9:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences has been upgraded from Neutral to Overweight by Piper Sandler, with a new price target of $90.
The upgrade from Piper Sandler is a positive signal for Exact Sciences. The new Overweight rating suggests that the analyst believes the company's stock will outperform the market in the near future. The new price target of $90 also indicates an expected increase in the stock's value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100